- ADJUNCT ASSOCIATE PROFESSOR Psychiatry
Fellowship, Child Mental Health
Albert Einstein College of Medicine
- Dr. Solanto is an Adjunct Associate Professor of Psychiatry at Mount Sinai School of Medicine. She completed her undergraduate education at Princeton University, and received her Ph.D. in Clinical Psychology from the University at Buffalo. She subsequently completed an NIMH post-doctoral in the Department of Psychiatry at the Albert Einstein College of Medicine.
Dr. Solanto’s research on the cognitive and behavioral functioning of children with ADHD, the effects of psychostimulants, and characteristics of the subtypes of ADHD has been supported by grants from the National Institute of Neurological Diseases, the National Institute of Mental Health and the National Institute of Child Health and Human Development. Dr. Solanto has also worked extensively with adults with ADHD. She developed a novel cognitive-behavioral intervention which targets problems of time-management and organization in adults with ADHD and was the focus of a recently completed NIMH-sponsored treatment efficacy study. The manual for therapists was published by Guilford Press (2011), titled, Cognitive-Behavioral Treatment of Adult ADHD: Targeting Executive Dysfunction.
Dr. Solanto is active in clinical work and in the training of psychiatrists and psychologists to diagnose and treat AD/HD and related disorders. She has conducted workshops with parents and teachers concerning identification and treatment of children with AD/HD, and has presented to adult groups on strategies to improve organization and self-management. Dr. Solanto has published numerous scholarly papers concerning ADHD in children and adults and is a frequent reviewer for professional journals. She has served as a grant reviewer for NIMH. Currently, she is a member of the advisory board of the Journal of Child Psychology and Psychiatry and is a member of the editorial board of the Journal of Attention Disorders and the ADHD Report. She serves on the professional advisory boards of CHADD (Children and Adults with ADHD) and the American Professional Society of ADHD and Related Disorders. Dr. Solanto edited a book (with Amy Arnsten and Xavier Castellanos) titled: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience, (Oxford University Press), which is an investigation the mechanisms of action of stimulants in ADHD.
In the News
2011 - Innovative Program of the Year Award. More.
Dr. Solanto discusses a new Attention Disorder study in The Daily News feature The Daily Check Up. View the PDF.
Wall Street Journal - "Mind Games: Attention-Deficit Disorder Isn't Just for Kids. Why Adults Are Now Being Diagnosed, Too." View the Article
Parade Magazine - "Do you have ADHD?" View the Article
Diagnosis of ADHD in adults and children
Cognitive-behavioral treatment of ADHD
Nosology of ADHD, specifically subtyping
Neuropsychological functioning in children and adults with ADHD
Effects of stimulant medications on cognitive and behavioral functioning
Effects of reinforcement (reward) in children with ADHD
Milton Rosenbaum Research Award, first place
Department of Psychiatry, Albert Einstein College of Medicine
Elaine Schlosser Lewis Award for Research in ADHD
American Academy of Child and Adolescent Psychiatry
Matthew Vassar Scholar
James A. Shannon Award
National Institute of Child Health and Human Development
Innovative Program of the Year Award
CHADD (Children and Adults with ADHD)
Dr. Solanto's research has been supported by grants from the National Institute of Mental Health, the National Institute of Child Health and Human Development, and the National Institute on Neurological Diseases and Stroke. Her interests include:
- Neuropsychological functioning in children and adults with ADHD
- Time-action and dose-response effects of methylphenidate (Ritalin) on behavior and psychophysiology
- Effects of stimulant medications on cognitive and behavioral functioning
- Neurobiological mechanisms of action of stimulants
- Effects of reinforcement (reward) in children with ADHD
- Differentiating Combined and Predominantly Inattentive subtypes of ADHD
- Diagnosis of ADHD in adults
- Psychosocial interventions for adults with ADHD
Willcut E, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, Loo SK, Carlson CL, McBurnett K. Validity of DSM-IV attention–deficit/hyperactivity disorder symptom dimensions and subtypes. Journal of Abnormal Psychology 2012;.
Solanto MV, Marks DM, Wasserstein J, Mitchell K. Diagnosis of ADHD in Adults: What is the Appropriate DSM-5 Symptom Threshold for Hyperactivity-Impulsivity? . Journal of Attention Disorders 2012;.
Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of meta-cognitive therapy (MCT) for adult ADHD. American Journal of Psychiatry 2010; 167(8): 958-968.
Solanto MV, Newcorn JN, Gilbert SN, Vail L, Raj A, Ivanov I, Lara R. Stimulant drug response in ADHD, Predominantly Inattentive subtype. Journal of Child and Adolescent Psychopharmacology 2009; 19(6): 663-671.
Solanto MV, Schulz KP, Fin J, Tang CY, Newcorn JH. Event-related fMRI in the Predominantly Inattentive and Combined subtypes of AD/HD. Journal of Neuroimaging 2009; 19(3): 205-212.
Solanto MV, Gilbert SN, Raj A, Zhu J, Pope-Boyd S, Stepak B, Vail L, Newcorn JH. Neurocognitive functioning in AD/HD, Predominantly Inattentive Subtype. Journal of Abnormal Child Psychology 2007; 35(5): 729-744.
Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with ADHD. Archives of General Psychiatry 2007; 64(8): 932-940.
Solanto MV. Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research . Behavioural Brain Research 2002; 130: 65-71.
Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan G, Wigal T, Hechtman L, Hinshaw S, Pollock S, Terkel E. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH Multi-Modal Treatment Study of AD/HD. J Abnorm Child Psychol 2001; 29: 215-228.
Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention deficit/hyperactivity disorder: A review and integration. Behav Brain Research 1998; 94: 127-152.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Solanto did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
One Park Avenue
New York, NY 10016
19 East 98th Street, Suite 5D
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm